Updates to the clinical trials list

[vc_row][vc_column][vc_empty_space][vc_column_text]FOR PATIENTS THAT HAVE NOT HAD ANY PREVIOUS DRUG TREATMENT

• A Study of INCB 99280 in Combination with Ipilimumab for Patients with Advanced Kidney Cancer

[/vc_column_text][vc_column_text]

• A Study of MDNA11 Alone or in Combination with Pembrolizumab in Patients with Advanced Kidney Cancer

[/vc_column_text][vc_empty_space][vc_column_text]FOR PATIENT WHO HAVE HAD PREVIOUS DRUG TREATMENT

• A Study of 23ME-00610 in Patients with Advanced Kidney Cancer

[/vc_column_text][vc_column_text]

• A Study of BMS-986340 Alone or in Combination with Nivolumab for Patients with Advanced Kidney Cancer

[/vc_column_text][vc_column_text]

• A Study of GSK4381562 Alone or in Combination with Dostarlimab or GSK4428859A for Patients with Advanced Kidney Cancer

[/vc_column_text][vc_column_text]

• A Study of KFA115 Alone or in Combination with Tislelizumab in Patients with Advanced Kidney Cancer

[/vc_column_text][vc_column_text]

• A Study of MDNA11 Alone or in Combination with Pembrolizumab in Patients with Advanced Kidney Cancer

[/vc_column_text][vc_empty_space][vc_empty_space][/vc_column][/vc_row]